Literature DB >> 17084803

Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.

Wolfgang Schalch1, William Cohn, Felix M Barker, Wolfgang Köpcke, John Mellerio, Alan C Bird, Anthony G Robson, Fred F Fitzke, Frederik J G M van Kuijk.   

Abstract

The xanthophylls lutein (L) and zeaxanthin (Z) form the macular pigment with the highest density in the macula lutea. We investigated Macular Pigment Optical Density (MPOD) responses to supplementation with identically formulated (Actilease) L or Z (OPTISHARP) or L+Z over 6-12 months using doses of 10 or 20mg/day. MPOD as well as blue light sensitivity in fovea and parafovea were measured monthly by heterochromatic flicker photometry. Average xanthophyll plasma concentrations, analysed monthly by HPLC, increased up to 27-fold. MPOD increased by 15% upon L or L+Z supplementation. Supplementation of Z alone produced similar pigment accumulation in fovea and parafovea, which confounded MPOD measurements. After correction for this, a 14% MPOD increase resulted for Z. Thus, during supplementation with xanthophylls, L is predominantly deposited in the fovea while Z deposition appears to cover a wider retinal area. This may be relevant to health and disease of the retina.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084803     DOI: 10.1016/j.abb.2006.09.032

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  30 in total

1.  Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging.

Authors:  Masaki Tanito; Akira Obana; Yuko Gohto; Shigetoshi Okazaki; Werner Gellermann; Akihiro Ohira
Journal:  Jpn J Ophthalmol       Date:  2012-06-15       Impact factor: 2.447

2.  Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.

Authors:  David I Thurnham; John M Nolan; Alan N Howard; Stephen Beatty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-14       Impact factor: 3.117

Review 3.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 4.  [Vitamins for the eyes? Risks and opportunities for physician and patient].

Authors:  R Grossklaus; K J Henning
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

5.  Effect of 1-year lutein supplementation on macular pigment optical density and visual function.

Authors:  Yuzuru Sasamoto; Fumi Gomi; Miki Sawa; Motokazu Tsujikawa; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-18       Impact factor: 3.117

Review 6.  Measuring macular pigment optical density in vivo: a review of techniques.

Authors:  Olivia Howells; Frank Eperjesi; Hannah Bartlett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-08       Impact factor: 3.117

7.  Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance.

Authors:  Nikolaus Dragostinoff; René Marcel Werkmeister; Semira Kaya; Günther Weigert; Berthold Pemp; Stefan Sacu; Gerhard Garhöfer; Ursula Schmidt-Erfurth; Leopold Schmetterer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-25       Impact factor: 3.117

8.  Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters.

Authors:  Richard A Bone; John T Landrum
Journal:  Arch Biochem Biophys       Date:  2010-06-22       Impact factor: 4.013

Review 9.  Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration.

Authors:  Euna Koo; Martha Neuringer; John Paul SanGiovanni
Journal:  Am J Clin Nutr       Date:  2014-05-14       Impact factor: 7.045

Review 10.  Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.